Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 471 | 1 | 0.2 | 117 | 24.8 | 115 | 24.4 | 180 | 38.2 | 58 | 12.3 |
2015-2019 | 460 | - | - | 111 | 24.1 | 104 | 22.6 | 187 | 40.7 | 58 | 12.6 |
2014-2018 | 445 | - | - | 97 | 21.8 | 94 | 21.1 | 192 | 43.1 | 62 | 13.9 |
2013-2017 | 438 | - | - | 93 | 21.2 | 94 | 21.5 | 194 | 44.3 | 57 | 13.0 |
2012-2016 | 405 | - | - | 76 | 18.8 | 82 | 20.2 | 193 | 47.7 | 54 | 13.3 |
2011-2015 | 374 | - | - | 68 | 18.2 | 74 | 19.8 | 185 | 49.5 | 47 | 12.6 |
2010-2014 | 375 | 1 | 0.3 | 54 | 14.4 | 85 | 22.7 | 186 | 49.6 | 49 | 13.1 |
2009-2013 | 353 | 1 | 0.3 | 50 | 14.2 | 75 | 21.2 | 178 | 50.4 | 49 | 13.9 |
2008-2012 | 334 | 1 | 0.3 | 49 | 14.7 | 66 | 19.8 | 167 | 50.0 | 51 | 15.3 |
2007-2011 | 325 | 1 | 0.3 | 45 | 13.8 | 71 | 21.8 | 157 | 48.3 | 51 | 15.7 |
2006-2010 | 314 | 1 | 0.3 | 40 | 12.7 | 63 | 20.1 | 150 | 47.8 | 60 | 19.1 |
2005-2009 | 315 | - | - | 44 | 14.0 | 58 | 18.4 | 149 | 47.3 | 64 | 20.3 |
2004-2008 | 315 | - | - | 52 | 16.5 | 65 | 20.6 | 133 | 42.2 | 65 | 20.6 |
2003-2007 | 321 | - | - | 54 | 16.8 | 70 | 21.8 | 117 | 36.4 | 80 | 24.9 |
2002-2006 | 315 | - | - | 50 | 15.9 | 72 | 22.9 | 111 | 35.2 | 82 | 26.0 |
2001-2005 | 307 | - | - | 49 | 16.0 | 70 | 22.8 | 107 | 34.9 | 81 | 26.4 |
2000-2004 | 290 | - | - | 52 | 17.9 | 71 | 24.5 | 86 | 29.7 | 81 | 27.9 |
1999-2003 | 285 | - | - | 49 | 17.2 | 76 | 26.7 | 85 | 29.8 | 75 | 26.3 |
1998-2002 | 279 | - | - | 51 | 18.3 | 77 | 27.6 | 90 | 32.3 | 61 | 21.9 |
1997-2001 | 282 | - | - | 56 | 19.9 | 72 | 25.5 | 93 | 33.0 | 61 | 21.6 |
1996-2000 | 284 | - | - | 59 | 20.8 | 83 | 29.2 | 83 | 29.2 | 59 | 20.8 |
1995-1999 | 285 | - | - | 59 | 20.7 | 86 | 30.2 | 88 | 30.9 | 52 | 18.2 |
1994-1998 | 285 | - | - | 61 | 21.4 | 81 | 28.4 | 93 | 32.6 | 50 | 17.5 |
1993-1997 | 275 | - | - | 57 | 20.7 | 71 | 25.8 | 92 | 33.5 | 55 | 20.0 |
1992-1996 | 270 | - | - | 58 | 21.5 | 71 | 26.3 | 82 | 30.4 | 59 | 21.9 |
1991-1995 | 244 | - | - | 50 | 20.5 | 61 | 25.0 | 77 | 31.6 | 56 | 23.0 |
1990-1994 | 229 | - | - | 48 | 21.0 | 48 | 21.0 | 71 | 31.0 | 62 | 27.1 |
1989-1993 | 204 | - | - | 40 | 19.6 | 42 | 20.6 | 60 | 29.4 | 62 | 30.4 |
1988-1992 | 196 | 1 | 0.5 | 37 | 18.9 | 40 | 20.4 | 56 | 28.6 | 62 | 31.6 |
1987-1991 | 195 | 1 | 0.5 | 40 | 20.5 | 38 | 19.5 | 55 | 28.2 | 61 | 31.3 |
1986-1990 | 193 | 1 | 0.5 | 40 | 20.7 | 37 | 19.2 | 56 | 29.0 | 59 | 30.6 |
1985-1989 | 184 | 1 | 0.5 | 37 | 20.1 | 46 | 25.0 | 53 | 28.8 | 47 | 25.5 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |